Biogazelle is a provider of expert laboratory services focused on gene expression analysis. The company leverages RNA sequencing, digital PCR and software tools to deliver its laboratory services. Biogazelle was founded in 2007 as a Ghent University spin-off by Jan Hellemans (CEO) and Jo Vandesompele (CSO). It intends to use the new funding to further develop research on therapeutic RNA targets for specific cancer types and to expand its commercial activities. The recent financing reflects the company’s effort to support both R&D and commercial expansion.

Total raised

$3M

Funding rounds

1

Latest round

Series B

Latest activity

Oct 2014